ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024
LAUSANNE, Switzerland, Oct. 31, 2024 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the...
News
Muse Health™ Partners with FlyteHealth to Increase Access to Medical Obesity Care
Visionary healthcare company adds obesity and chronic care management provider to its curated selection of market-tested services NEW CANAAN, Conn.,...
Loftware and Signant Health Announce Availability of Integrated Clinical Supplies Labeling Solution
Automates to improve speed, enable compliance, and support scalability PORTSMOUTH, N.H., Oct. 31, 2024 /PRNewswire/ -- Loftware, the global leader...
Edison Issues Report on Metro Bank (MTRO)
London, United Kingdom--(Newsfile Corp. - October 31, 2024) - Edison issues report on Metro Bank (LSE: MTRO).Having successfully refinanced in...
Apollo Biowellness, Inc. Announces Joint Venture/Partnership with Reveal Lasers LLC for Expanded Distribution and Collaboration of Evo Bio Products.
North Bergen, New Jersey--(Newsfile Corp. - October 31, 2024) - Apollo Biowellness, Inc. (OTC Pink: KOAN) is pleased to announce...
Liviniti Supports Flexibility and Savings with Humira(R) Biosimilar Solutions
Lower cost therapeutic options added for treatment of inflammatory conditionsNatchitoches, Louisiana--(Newsfile Corp. - October 31, 2024) - Liviniti, a national...
Xcelerate, Inc. Announces Funding
MAULDIN, SC / ACCESSWIRE / October 31, 2024 / Xcelerate, Inc. (OTCQB:XCRT) (the "Company"), today announced that it has reached...
Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its “Abuse and Misuse Deterrent Transdermal System” Application
ORLANDO, FL / ACCESSWIRE / October 31, 2024 / Nutriband (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that theChinese National Intellectual Property Administrant (CNIPA)...
Star City Recovery: Luxury Rehab and Addiction Treatment Facility for Alcohol and Drugs in Tarzana, California
Detox Treatment With Different Options for Addiction No Matter What Substance You Struggle WithLOS ANGELES, CA / ACCESSWIRE / October...
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping Into a Booming $20 Billion Market
Projected to reach the $20 billion global mushroom market by 2030, CBDL's entry offers shareholders a unique opportunity to capitalize...
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
PALO ALTO, CA / ACCESSWIRE / October 31, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today...
Moderna to Present at Upcoming Conferences in November 2024
CAMBRIDGE, MA / ACCESSWIRE / October 31, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced its participation in the following upcoming...
Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant
The implant demonstrates stability and consistent drug release, supporting further analytical testing and development SARASOTA, FL, Oct. 31, 2024 (GLOBE...
Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events
BASKING RIDGE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative...
Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach
Digital Marketing Initiatives to Highlight Innovative Non-Invasive Drug Screening Technology and Market Expansion PlansNEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE)...
Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024
Conference call and webcast to begin at 8:30 AM ETAUSTIN, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc....
IMUNON to Hold Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 7, 2024
LAWRENCEVILLE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated...
Palisade Bio Announces Positive Data from Two Ex Vivo Translational Studies of PALI-2108 for the Treatment of Ulcerative Colitis
Targeted, better-tolerated oral PDE4 inhibitors are an unmet need in inflammatory bowel disease (IBD) PALI-2108 demonstrates in ex vivo studies;...
Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit
Poster presentation at SITC to highlight extended follow-up data from AMPLIFY-7P Phase 1 study Oral presentation at SU2C Innovation Summit...
SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE
DENVER, Oct. 31, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary...